Association between herpetic burden and chronic ischemic heart disease: Matched case-control study;Asociación entre la carga herpética y la enfermedad isquémica crónica del corazón: Estudio de casos y controles

Medicina Clinica

Volumn 137, Issue 4, 2011, Pages 157-160

  Esteban Hernández, Jesús ^a   San Román Montero, Jesús ^a   Gil, Ruth ^a   Anegón, María ^a   Gil, Ángel ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Case control studies; Herpesviridae infections; Myocardial ischemia; Risk factors; Seroepidemiologic Studies

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY PRODUCTION; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHRONIC DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HEALTH LITERACY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; SERODIAGNOSIS; SMOKING; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SMOKING; VIRAL LOAD;

EID: 79958851293     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.09.029     Document Type: Article

References (16)

1. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 1999;100:e20-8.
2. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol. 2003;92:515-21. (Pubitemid 37013401)
3. Rothenbacher D, Brenner H, Hoffmeister A, Mertens T, Persson K, Koenig W. Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis. 2003;170:339-45. (Pubitemid 37377808)
4. Sheehan J, Kearney PM, Sullivan SO, Mongan C, Kelly E, Perry IJ. Acute coronary syndrome and chronic infection in the Cork coronary care case-control study. Heart. 2005;91:19-22. (Pubitemid 39664984)
5. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001;103:45-51. (Pubitemid 32050434)
6. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104:25-31. (Pubitemid 32623285)
7. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21. (Pubitemid 34049136)
8. Guijarro C, Mesa N, Jiménez J, Puras E, Sánchez C, Fernández-Sánchez FJ, et al. Similitudes y diferencias entre los pacientes con aterosclerosis sintomática de distintos territorios. Cohorte AIRVAG (Atención Integral al Riesgo VAscular Global). Med Clin (Barc). 2006;127:605-11.
9. Fernández-Miranda C, Paz M, Aranda JL, Fuertes A, Gómez de la Cámara A. Infección crónica por Chlamydia pneumoniae en pacientes con enfermedad coronaria. Relación con el incremento de los valores de fibrinógeno. Med Clin (Barc). 2002;119:561-4.
10. Gomez E, Laures A, Baltar JM, Melon S, Diez B, de Oña M. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation. Transplant Proc. 2005;37:3760-3.
11. Gallego-Luis R, Ruiz-García A, Gordillo-López FJ, Díaz-Puente MV, Esteban J, Gil de Miguel A. Estudio de casos y controles no emparejados: hiperhomocisteinemia y cardiopatía isquémica crónica. Aten Primaria. 2006;37:325-31.
12. Liddell FD. Simplified exact analysis of case-referent studies: matched pairs; dichotomous exposure. J Epidemiol Community Health. 1983;37:82-4. (Pubitemid 13156400)
13. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C- reactive protein levels. Am J Cardiol. 2000;85:140-6. (Pubitemid 30026092)
14. EPIDAT. Programa para análisis epidemiológico de datos tabulados [Programa informático]. Version 3.1 Dirección Xeral de Saú de Pública. Consellería de Sanidade-Xunta de Galicia. Área de Análisis de Salud y Sistemas de Información Sanitaria. Organización Panamericana de Salud (OPS/OMS); 2006.
15. Aiello AE, Diez-Roux A, Noone AM, Ranjit N, Cushman M, Tsai MY, et al. Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis. Brain Behav Immun. 2009;23:663-71.
16. Steptoe A, Shamaei-Tousi A, Gylfe A, Henderson B, Bergstrom S, Marmot M. Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart. 2007;93:1567-70. (Pubitemid 350205551)